We can conclude that proteomic and genomic changes in tau protein, which are associated with Alzheimer’s disease pathology, contribute to the neurodegeneration of the brain after ischemia with the development of the type of Alzheimer’s disease dementia [12,22,112,113]. Here, MAPT is linked to Alzheimer disease.